1 The abbreviations used are ABC, ATP-binding cassette; P-gp, P-glycoprotein; ClogP, calculated logP; MIC, minimum inhibitory concentration; YPD, yeast extract, peptone, dextrose medium; YPG, yeast extract, peptone, glycerol medium; SD, synthetic dextrose medium; tritylimidazole, 
INTRODUCTION
In Saccharomyces cerevisiae, broad-spectrum resistance to structurally and mechanistically diverse inhibitors is mediated by several members of the ATP-binding cassette ( 
ABC)
1 superfamily of transporters, including Pdr5p, a 160-kDa ABC transporter found in the plasma membrane. Pdr5p is essential for basa1 levels of resistance to a broad array of substrates, including antifungal and antitumor agents, hormones, and ionophores (1) (2) (3) (4) . Compared with isogenic wild-type strains, pdr5 loss-of-function mutants exhibit hypersensitivity because of their inability to efflux inhibitors (3, 5) .
Although an important study (3) provided strong indirect evidence for the existence of more than one substrate-binding site, the chemical basis of Pdr5p substrate specificity is unclear. One reason is that many of the compounds analyzed to date are complex in chemical structure. As an alternative approach, we searched for a series of relatively simple compounds that were systematically related to each other in structure but varied in their ability to serve as Pdr5p substrates. By comparing several series, we hoped to identify shared properties that are used in the Pdr5p-substrate interaction. In the initial study, we compared the relative resistance of isogenic PDR5 ( wild-type) and pdr5 ( loss-of-function mutant) strains toward a series of tri-n-alkyltin chlorides of increasing alkyl chain length. These compounds are potent inhibitors of mitochondrial ATPases and are not substrates for at least two other major ABC yeast transporters, YOR1 and SNQ2 (6) . Initial results suggested that size and ionization might be 7 (Beckman-Coulter, Columbia, MD). [ 3 H]-tritylimidazole efflux was analyzed directly by measuring the efflux rather than by using steady state conditions. The cells were loaded for 3 h with the same general protocol described for [ 3 H]-chloramphenicol. Following this, samples were chilled on ice for 5 min, centrifuged at 4 °C, and washed once in 1 ml cold 0.05M Hepes buffer before resuspension in 250 µl of this buffer containing 1 mM glucose in the presence or absence of inhibitors. Samples were incubated for various times at 30 °C. Following this, 600 µl of cold buffer (pH 7.0) was added, and the samples were placed on ice for 5 min. Because tritylimidazole adheres to filters, the samples were centrifuged at 4 °C and washed once in cold 0.05 Hepes buffer before resuspension in 125 µl for counting. Under these conditions, background counts averaging ~2400 cpm were observed. This value was subtracted from the total to calculate the amount of retained tritylimidazole.
RESULTS

Pdr5p Does Not Require Ionization of Substrates or Electron-Pair Donor-The
trialkyltin chlorides and many substrates mediated by Pdr5p are capable of ionization to varying degrees. Nevertheless, Kolaczkowski et al. (3) showed that progesterone, with no ionizable groups, is also a Pdr5p substrate. We confirmed the ability of Pdr5p to confer resistance to nonionizing compounds by analyzing three tetraalkyltins: propyl, butyl, and pentyl (the methyl and ethyl derivatives are not toxic in yeast at the highest concentrations that we were able to use).
These results are shown in Table II . All three are strong Pdr5p substrates. This was observed by comparing the MICs derived on solid media for isogenic PDR5 and pdr5 strains. The MICs for tetraalkyltins using the PDR5 strain were 10-to 50-fold higher than the pdr5-null mutant strain JG436. The tetraalkyltins are simple structures without electron-pair donors and in this respect are unlike other Pdr5p substrates described to date. Thus, the possibility that the hypersensitivity was caused by a coincidental mutation in another gene rather than in PDR5 had to be considered and was investigated by genetic analysis. The ura3, PDR5 (wild-type) strain RW2802 was mated to DYK2.1 (10) , which carries a URA3-marked deletion of PDR5. The resulting diploid was sporulated and subjected to tetrad analysis to determine whether hypersensitivity to tetrabutyltin cosegregated with the URA3 allele. There was complete cosegregation in 17 tetrads scored for these phenotypes. Five petite segregants (mitochondrial deficient and unable to grow on glycerol)
were not scored. Of the remaining 55 segregants, 29 Ura + (pdr5) spores were all hypersensitive 9 lists the MICs for JG436 and RW2802. To verify that the phenotypic differences observed with JG436 and RW2802 are caused by differences at PDR5, another pair of isogenic strains, SC 4741
(PDR5) and SC2909 (pdr5::gent r ), were included in this study (data not shown). With two exceptions noted below, the results with the latter pair of strains were similar or identical to those obtained with JG436 and RW2802. In both pairs of strains, significant differences were observed with some of the aromatic imidazole compounds. Phenyl and benzylimidazole are weak substrates at best (MIC ratios in both sets of strains are 1-2), but large differences are found with bifonazole, tritylimidazole, and clotrimazole (Table II) . MICs were also derived for organotin compounds (Table II) , some of which were used in our previous analysis (6) . No differences between these strains were observed for trimethyltin chloride, an observation in accord with our initial study (6) .
The large difference between PDR5 and pdr5 strains observed with tripentyltin chloride of ~200-to 300-fold was in marked contrast to our initial report of no difference (6) . There was no obvious explanation for this other than the fact that the compound used in this study was purchased from a new source and was probably purer than the previous sample. Thin-layer chromatography indicated that the new material was ~97-98% pure, as advertised (J. Sczepanski and L. May, unpublished observations). There was a significant difference between the two sets of strains with regard to their relative bifonazole and tricyclohexyltin chloride resistance. With regard to the former, the JG436/RW2802 set gave a difference of ~80-fold, whereas the difference between SC4741 and SC2909 was only ~8-fold. Similarly, with tricyclohexyltin chloride, the RW2802/JG436 pair gave an MIC ratio of 50-fold. The SC4741/SC2909 set yielded a ratio of two. It remains to be determined whether this disparity reflects differences at PDR5 or at some other gene.
The effect of single-deletion mutations in SNQ2 and YOR1 on imidazole resistance was investigated in strains that are isogenic to SC4741. We showed previously that the proteins encoded by these genes do not mediate resistance to trialkyltin chlorides (6 
Is the Size Requirement for Pdr5p-Substrate Interaction Independent of
Hydrophobicity?-Evidence strongly indicates that hydrophobicity as measured by ClogP is an important property in the interaction between substrates and the mammalian multidrug-resistance transporters such as P-gp (7, 8) . Because hydrophobicity often increases with substrate size, the relationship of these two properties in a series of structurally related compounds is difficult to ascertain. The organotin compounds, however, offered such an opportunity because it was possible to find examples of similar size and structure but different degrees of hydrophobicity.
Thus, tripropyltin chloride and dibutyltin dichloride have surface volumes within 3 Å 3 of each other, but their ClogP values differ by an order of magnitude (Table III) . The latter is considerably more hydrophilic because it has an additional polar chlorine group. Nevertheless, the two compounds gave very similar MIC ratios (~10-fold) between PDR5 and pdr5 strains, suggesting that substrate size is of critical importance and is independent of any hydrophobicity requirement in the interaction of Pdr5p and its substrates. This supposition is reinforced by the observation that the optimal substrates from each of the series (tetraalkyltins, imidazoles, trialkyltin chlorides), are all in the range of 200-225 Å 3 , although their ClogP values vary from 4.34 to 10 (Table III) .
Relative Resistance of Imidazole and Organotin Chlorides in a Strain That Overproduces
Pdr5p.-Classic multidrug resistance is often associated with overexpression of ABC transporters. AD124567, a strain that has deletions of 5 important drug transporters but overproduces pdr5p because of a PDR1-3 mutation (2) and is not isogenic to RW2802 was used in our transport assays. Therefore, it was important to determine whether its substrate specificity was different. MICs were derived from AD124567 and the isogenic AD1-7 control stock, which also contains a pdr5 deletion. These data are found in Table IV . Efficacy is expressed as in Table   II . Not surprisingly, moderate-to-strong inhibitors (bifonazole, tritylimidazole, clotrimazole, tetrapropyltin, tripropyltin, tributyltin, and tripentyltin chlorides) yielded MICs that were considerably higher in the overproducing strain than in wild-type strains. In contrast, the compounds that gave little or no difference (twofold or less) in MIC between wild-type and mutant strains also yielded similar MICs when AD1-7 and AD124567 were compared. These observations mean that the conclusions reached with the overexpressing strain should be generally applicable to strains with wild-type levels of Pdr5p. Examination of the MIC ratios for the tri-n-alkyltin chlorides was also instructive. Unlike the case for the wild-type strains, RW2802 and SC4741, the ratio increased steadily as the number of carbons increased. The data also indicated that the MICs derived for the organotin chlorides in the multiple ABC transporter deletion strain AD1-7 were similar to single pdr5-null mutants. Therefore, other ABC loci are not major mediators of resistance to these compounds. Because the hyperresistant strain AD124567 effluxes drug at an even faster rate than the wildtype strain used in the original study (J. Golin, unpublished observations), we decided to employ steady state conditions. The assumption that the steady state difference between the strains in chloramphenicol accumulation reflects Pdr5p efflux was confirmed in the experiment illustrated in Fig 3A, where accumulation is plotted as a function of substrate concentration in both the PDR5 overproducer and its isogenic pdr5 counterpart, AD1-7. Though the former accumulated two-to threefold less substrate, both strains exhibit uptake that is linear and unsaturable. This indicated that influx is not carrier dependent. Furthermore, the addition of 100 mM 2-deoxyglucose to assays with the overproducing strain resulted in kinetics that were indistinguishable from those obtained with the pdr5 mutant. Addition of this inhibitor to pdr5 mutant cultures, however, did not change the retention kinetics. Thus, the observed difference between the two strains was the result of energy-driven Pdr5p-mediated efflux.
Effect of Substrates on Chloramphenicol Efflux-In
To determine whether the imidazole derivatives and the organotin compounds are competitive inhibitors of Pdr5p-mediated chloramphenicol efflux, the transport assay described in Experimental Procedures was performed in the presence of clotrimazole, tritylimidazole, tripentyltin chloride, tributyltin chloride, tricyclohexyltin chloride, and triphenyltin chloride. In addition, the effect on transport of tetrapropyltin and the antitumor agent doxorubicin was also evaluated. The first three compounds are of particular interest because they are strong substrates of very similar size. The results are shown in Fig. 3B . Several important points bear mention.
First, none of the organotin compounds caused significant levels of inhibition (Fig. 3B) , even though the concentrations used (50 µM) were considerably above the MICs for the pdr5 mutant.
Second, as indicated by the plot in Fig. 3C Significantly, clotrimazole, which is a stronger Pdr5p substrate than is tripropyltin chloride, nevertheless showed relatively weaker inhibition of tritylimidazole efflux. These data are summarized in Table V .
DISCUSSION
In yeast, a basal level of broad-spectrum drug resistance is mediated in large part by
Pdr5p, an ABC transporter that has been studied extensively (see Ref.
11 for a recent review). In this report, we demonstrate that Pdr5p effluxes substrates that are much simpler in structure than many of the previously studied antifungal or antitumor agents (11) . Our data suggest that molecular size is of critical importance. Because hydrophobicity also increases with size, it could be concluded that it is the former that drives the interaction between Pdr5p and its substrates.
Several pieces of evidence suggest, however, that the size requirement is independent of any requirement for hydrophobicity. The first is a comparison of two compounds: tripropyltin chloride and dibutyltin dichloride. These are of similar size but have ClogPs that vary by 10-fold.
Nevertheless, the MIC ratios for these substrates are not significantly different. A similar conclusion is reached by comparing tributyltin chloride, tetrapropyltin, and triphenyltin chloride.
Although their ClogPs vary from 3.56 to 7.9, their surface volumes are very similar (176 183
and all three compounds yield nearly the same MIC ratios. The second significant observation is that the most effective compound in each series has a molecular size in the 200-225 Å 3 range regardless of ClogP values (which range from 4.34 to 10). A size dependence for P-gp drugbinding capability was also observed (12) . In wild-type yeast strains, plots of trialkyltin chloride substrate efficacy (MIC ratios) versus surface volume (Fig. 2) show a modest initial sizedependent increase followed by a leveling or even a slight decline with tributyltin chloride followed by a second peak. The Pdr5p-overproducing strain failed to show this behavior. Instead, there is a steady size-dependent increase. It is possible that another gene product present in pdr5 mutants mediates some resistance to tributyltin chloride. In the Pdr5p-overproducing strain, this as yet unidentified protein's effect would be masked.
It is known that Pdr5p mediates significant resistance to a variety of antitumor agents, dyes, small peptides, and hormones (3, 11) . Most of these agents are significantly larger than even the biggest molecules in the various series tested in this study. The organotin compounds are markedly different from other Pdr5p (3) and P-gp (7, 8) substrates. There was no difference in the killing curves obtained for isogenic multidrug-resistant and sensitive human cell (KB-3-1 and KB-V1, respectively) lines when challenged with tetrabutyltin and tripentyltin chloride (C. Cardarelli, unpublished observations). Seelig (7) and Seelig and Landwojtowicz (8) presented evidence indicating that an important component of a Pgp-substrate is the presence of at least two electron-pair donor groups at fixed distances from each other. The importance of electron-pair donors in P-gp-substrate interactions was recently demonstrated for a series of eight anthracyclines that are closely related to doxorubicin (13) .
Other studies with analogues of verapamil and colchicine (reviewed in Ref. 14) support this idea.
The tetraalkyltins are extreme exceptions, as they have no electron-pair donors. At first glance, it is not surprising that these are not competitive inhibitors of chloramphenicol, which resembles Pgp substrates (although its volume is smaller than most). In fact, the organotin compounds appear to define two additional binding sites on Pdr5p: those like tripentyltin chloride that compete with at this putative third site remains to be determined, although the extreme simplicity of the tetraalkyltins suggests that a hydrophobic interaction may be critical. How these sites are organized, of course, remains unknown. For instance, they might be distinct or overlapping.
Several other observations should be emphasized. Although tritylimidazole and clotrimazole are equally strong Pdr5p substrates, the latter is 10-fold more effective as a competitive inhibitor of chloramphenicol efflux. In contrast, clotrimazole shows weaker inhibition in the tritylimidazole efflux assay when compared to tripropyltin chloride, a rather modest Pdr5p substrate. This is consistent with our observation that tritylimidazole and clotrimazole interact with Pdr5p at more than one site with varying affinity. It is possible that although tripropyltin chloride is a strong inhibitor of tritylimidazole efflux, it interacts at fewer binding sites than the larger, more complicated substrates. The difference between the two imidazoles is a single chlorine group. It would be tempting to argue that the clotrimazole/chloramphenicol-binding site resembles that of P-gp because both compounds have strong electron-pair donor groups such as chlorine and oxygen. Furthermore, P-gp is known to mediate resistance to azole antifungals such as ketoconazole and fluconazole (15), although these are more complex in structure than the imidazoles used in this study. The inability of the strong P-gp substrate doxorubicin to compete with chloramphenicol argues that the details of Pdr5p-substrate interaction are different than those observed in mammalian cells.
Leonard, Golin, and Rathod (5) first noted the discrepancy between the relative difference in the sensitivity between PDR5 and pdr5 strains toward chloramphenicol (20-fold) compared to that of efflux (4-fold). This discrepancy was observed in the present study to an even larger degree with tritylimidazole. A number of obvious explanations were ruled out, including inadequate buffer conditions and saturating levels of substrate. It is also possible that due to its hydrophobic nature, the efflux of tritylimidazole is underestimated.
In summary, our data demonstrate that Pdr5p-substrate interaction has a size dependence that is independent of the requirement for hydrophobicity. The MICs for inhibitors are shown in Table III as a range of concentrations. The midpoint of the MIC range derived for RW2802 (PDR5) and JG436 (pdr5 deficient) was used to construct an MIC ratio for each compound. ■, imidazoles; ▲, trialkyltin chlorides; o, tetraalkyltins. 
